Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.
Treatment options for primary and secondary liver tumors that cannot be resected or ablated are based on transarterial techniques. Although the majority of these are based on bland and chemoembolization techniques, yttrium-90 microspheres represent an alternate transarterial option. Although the amount of literature on (90)Y does not rival that of bland or chemoembolization, there nevertheless are ample data that support its use for primary and metastatic liver tumors. A comprehensive review of the entire available literature dating from the early 1960s is presented, as is a discussion of the possibilities for future research with use of radioembolization as a platform.
Salem
Riad
R
Department of Radiology, Robert H. Lurie Comprehensive Cancer Center, 676 North St Clair, Suite 800, Chicago, IL 60611, USA. r-salem@northwestern.edu
Thurston
Kenneth G
KG
D001918:Brachytherapy / Q000379:methods* / Q000639:trends; D004621:Embolization, Therapeutic / Q000379:methods* / Q000639:trends; D006801:Humans; D008113:Liver Neoplasms / Q000532:radiotherapy* / Q000556:secondary*; D011868:Radioisotopes / Q000627:therapeutic use; D015021:Yttrium Radioisotopes / Q000627:therapeutic use*
D011868:Radioisotopes; D015021:Yttrium Radioisotopes